The PAREXEL Medical Communications Health Policy and Strategic Reimbursement group partners with clients to develop strategic solutions to overcome barriers to payment for biotechnology, pharmaceuticals, and medical devices.
Our capabilities include a comprehensive understanding of coverage and payment issues related to a product's use from private and public third-party perspectives.
We work with clients on a range of reimbursement services and policy analysis to remove barriers to product acceptance to further assist patients with gaining access.
- Through PAREXEL HELPlines and exceptional case management, our success rate in overturning denied or underpaid claims averages 85% to 90%.
- The PAREXEL Value of Success cost savings program locates alternative payment resources for patients. As an example of our proven success, for one client alone, PAREXEL reported an estimated annual savings of over $8 million for an oncology product and over $38 million for a non-oncology product.
We also closely monitor the potential impact of new state and federal health policies, laws, and regulations, and demonstrate a product's value to public and private payers.